Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.71 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.71 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.50 |
| ▸ | OXER1 | Q8TDS5 | 4/20 | 0.50 |
| ▸ | PPARG | P37231 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | RXRA | P19793 | 2/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.46 |
| ▸ | F7 | P08709 | 3/20 | 0.46 |
| ▸ | F3 | P13726 | 3/20 | 0.46 |
| ▸ | PPARA | Q07869 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | PPARD | Q03181 | 2/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26621 | 1.00 | — | — | |
| SCHEMBL1129707 | 1.00 | — | — | |
| SCHEMBL37416 | 1.00 | — | — | |
| SCHEMBL16028753 | 1.00 | ALDH1A1 (0.71) | ALDH1A1ALOX15CYP2D6CYP19A1OXER1 | |
| SCHEMBL11329669 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL1375884 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL1375887 | 0.97 | — | — | |
| Ethylene SCHEMBL29194016 | 0.95 | ALDH1A1 (0.63) | ALDH1A1ALOX15CYP2D6CYP19A1OXER1 | |
| Ethylene SCHEMBL6138361 | 0.95 | ALDH1A1 (0.63) | ALDH1A1ALOX15CYP2D6CYP19A1OXER1 | |
| Acetic Acid SCHEMBL17459602 | 0.95 | ALDH1A1 (0.63) | ALDH1A1ALOX15CYP2D6CYP19A1OXER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970169-A1 | GLYCITAN ESTERS OF UNSATURATED FATTY ACIDS AND THEIR PREPARATION | Elevance Renewable Sciences, Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| US-20150307469-A1 | Glycitan Esters of Unsaturated Fatty Acids and Their Preparation | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2015-10-29 | — | — | US | disclosed |
| US-9045447-B2 | Glycitan esters of unsaturated fatty acids and their preparation | Elevance Renewable Sicences, Inc. (US) | 2015-06-02 | — | — | US | disclosed |
| WO-2014159226-A1 | GLYCITAN ESTERS OF UNSATURATED FATTY ACIDS AND THEIR PREPARATION | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2014-10-02 | — | — | WO | disclosed |
| US-20140275580-A1 | GLYCITAN ESTERS OF UNSATURATED FATTY ACIDS AND THEIR PREPARATION | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2014-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140275580-A1 | GLYCITAN ESTERS OF UNSATURATED FATTY ACIDS AND THEIR PREPARATION | SGMS1, SCD5, FADS1 | ALDH1A1 1724/4885ALOX15 22/4885CYP2D6 2284/4885 |
| US-20150307469-A1 | Glycitan Esters of Unsaturated Fatty Acids and Their Preparation | SGMS1, SCD5, FADS1 | ALDH1A1 1724/4885ALOX15 22/4885CYP2D6 2284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.